Position in GPCR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,807,114
-$3,335,360 QoQ
Shares Held
89,568
-47.0% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 190 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GPCR Over Time
Shares Held
Position Value (USD)
Derivatives in GPCR
reported options exposure · as of Dec 31, 2024CallValue
$6,346,080
CallShares
234,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. GPCR ranks #169 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in GPCR
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,807,114 | 89,568 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,142,474 | 168,931 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,610,548 | 152,560 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $35,687,428 | 1,274,551 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $25,303,940 | 1,220,055 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $13,677,652 | 790,159 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $20,367,472 | 751,013 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $6,346,080 | 234,000 | Call | Sole | 2025-02-14 | |
| 2024-09-30 | $9,173,010 | 209,000 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $40,003,584 | 911,451 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,239,775 | 82,500 | Call | Sole | 2024-08-14 | |
| 2024-06-30 | $44,739,996 | 1,139,292 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $1,515,822 | 38,600 | Put | Sole | 2024-08-14 | |
| 2024-03-31 | $3,897,774 | 90,942 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $683,504 | 16,769 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $366,840 | 9,000 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $2,853,200 | 70,000 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $15,119,647 | 299,874 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,838,474 | 44,226 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $843,569 | 35,459 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||